Market Research Logo

OncoTherapy Science, Inc. - Product Pipeline Review - 2015

OncoTherapy Science, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘OncoTherapy Science, Inc. - Product Pipeline Review - 2015’, provides an overview of the OncoTherapy Science, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of OncoTherapy Science, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of OncoTherapy Science, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of OncoTherapy Science, Inc.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the OncoTherapy Science, Inc.’s pipeline products
Reasons to buy
  • Evaluate OncoTherapy Science, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of OncoTherapy Science, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the OncoTherapy Science, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of OncoTherapy Science, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of OncoTherapy Science, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of OncoTherapy Science, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


OncoTherapy Science, Inc. Snapshot
OncoTherapy Science, Inc. Overview
Key Information
Key Facts
OncoTherapy Science, Inc. - Research and Development Overview
Key Therapeutic Areas
OncoTherapy Science, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
OncoTherapy Science, Inc. - Pipeline Products Glance
OncoTherapy Science, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
OncoTherapy Science, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
OncoTherapy Science, Inc. - Unknown Stage Pipeline Products
Unknown Products/Combination Treatment Modalities
OncoTherapy Science, Inc. - Drug Profiles
elpamotide
Product Description
Mechanism of Action
R&D Progress
OCVC-01
Product Description
Mechanism of Action
R&D Progress
OTSGC-A24
Product Description
Mechanism of Action
R&D Progress
ONO-7268MX1
Product Description
Mechanism of Action
R&D Progress
ONO-7268MX2
Product Description
Mechanism of Action
R&D Progress
OTS-167
Product Description
Mechanism of Action
R&D Progress
OTSA-101
Product Description
Mechanism of Action
R&D Progress
OTS-964
Product Description
Mechanism of Action
R&D Progress
OncoTherapy Science, Inc. - Pipeline Analysis
OncoTherapy Science, Inc. - Pipeline Products by Target
OncoTherapy Science, Inc. - Pipeline Products by Route of Administration
OncoTherapy Science, Inc. - Pipeline Products by Molecule Type
OncoTherapy Science, Inc. - Pipeline Products by Mechanism of Action
OncoTherapy Science, Inc. - Recent Pipeline Updates
OncoTherapy Science, Inc. - Dormant Projects
OncoTherapy Science, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
OncoTherapy Science, Inc., Key Information
OncoTherapy Science, Inc., Key Facts
OncoTherapy Science, Inc. - Pipeline by Indication, 2015
OncoTherapy Science, Inc. - Pipeline by Stage of Development, 2015
OncoTherapy Science, Inc. - Monotherapy Products in Pipeline, 2015
OncoTherapy Science, Inc. - Out-Licensed Products in Pipeline, 2015
OncoTherapy Science, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015
OncoTherapy Science, Inc. - Phase II, 2015
OncoTherapy Science, Inc. - Phase I, 2015
OncoTherapy Science, Inc. - Preclinical, 2015
OncoTherapy Science, Inc. - Unknown, 2015
OncoTherapy Science, Inc. - Pipeline by Target, 2015
OncoTherapy Science, Inc. - Pipeline by Route of Administration, 2015
OncoTherapy Science, Inc. - Pipeline by Molecule Type, 2015
OncoTherapy Science, Inc. - Pipeline Products by Mechanism of Action, 2015
OncoTherapy Science, Inc. - Recent Pipeline Updates, 2015
OncoTherapy Science, Inc. - Dormant Developmental Projects,2015
OncoTherapy Science, Inc., Subsidiaries
List of Figures
OncoTherapy Science, Inc. - Pipeline by Top 10 Indication, 2015
OncoTherapy Science, Inc. - Pipeline by Stage of Development, 2015
OncoTherapy Science, Inc. - Monotherapy Products in Pipeline, 2015
OncoTherapy Science, Inc. - Out-Licensed Products in Pipeline, 2015
OncoTherapy Science, Inc. - Pipeline by Top 10 Target, 2015
OncoTherapy Science, Inc. - Pipeline by Top 10 Route of Administration, 2015
OncoTherapy Science, Inc. - Pipeline by Top 10 Molecule Type, 2015
OncoTherapy Science, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report